BioSpace News Archive

Positive Data Presentations at AAO Annual Meeting Demonstrate Utility and Versatility of Clearside Biomedical’s Proprietary Suprachoroidal Space Platform

Clearside Biomedical, Inc. announced today that clinical data from multiple internal and partnered programs were presented at the recent 2022 Annual Meeting of the American Academy of Ophthalmology (AAO), the world’s largest association of eye physicians and surgeons.

October 4, 2022
·
7 min read
Biotech Beach

Helixmith to Present New ALS-Focused Development Program at Upcoming Conferences

Helixmith announced that their CEO, Dr. Sunyoung Kim, will be presenting an overview of their ALS-focused program, named DART, Defeating ALS through Regenerative Therapeutics, at both the 2022 Cell & Gene Meeting on the Mesa and the 2022 BIO-Europe Conference.

October 4, 2022
·
3 min read
BioForest

Lumen Bioscience Announces Publication in NPJ Vaccines of Preclinical Data Demonstrating Needle Free, Spirulina-produced Vaccination Offering Protection Against Malaria

Lumen Bioscience today announced the publication of data demonstrating a needle-free, spirulina-produced recombinant vaccine that protects against malaria.

October 4, 2022
·
2 min read
Business

miRecule Enters into Strategic Collaboration with Sanofi to Accelerate Discovery and Development of a Best-in-Class Antibody-RNA Conjugate to Treat Facioscapulohumeral Muscular Dystrophy (FSHD)

miRecule Enters into Strategic Collaboration with Sanofi to Accelerate Discovery and Development of a Best-in-Class Antibody-RNA Conjugate to Treat Facioscapulohumeral Muscular Dystrophy (FSHD).

October 4, 2022
·
4 min read
Business

Harpoon Therapeutics Appoints Luke Walker, M.D., as Chief Medical OfficerHarpoon adds experienced drug developer to leadership team

Harpoon Therapeutics, Inc. today announced the appointment of Luke Walker, M.D., as Chief Medical Officer.

October 4, 2022
·
6 min read
Genetown

iSpecimen Launches Marketplace Onsite Program to Optimize Biospecimen Procurement Process for Sample ProvidersNew Program Designed to Support Provider Partners with Onsite Coordinator

iSpecimen Inc. today launched its new Marketplace Onsite program to offer additional support to the Company’s biospecimen provider partners.

October 4, 2022
·
4 min read
Drug Development

Abeona Therapeutics Announces Completion of Patient Follow-up in Pivotal Phase 3 VIITAL™ Study of EB-101 in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the last patient has completed their 6-month follow-up visit in Abeona’s pivotal Phase 3 VIITAL™ study of its investigational autologous, engineered cell therapy, EB-101, in patients with recessive dystrophic epidermolysis bullosa (RDEB).

October 4, 2022
·
4 min read
Genetown

Innovation Pharmaceuticals Announces Publication of Scientific Article on the Antifungal Activity of Brilacidin

Innovation Pharmaceuticals today announced publication of a scientific article on the antifungal activity of Brilacidin, the Company’s defensin-mimetic drug candidate with antimicrobial and immunomodulatory properties.

October 4, 2022
·
7 min read
Pharm Country

Biohaven Sets New Course with $258 Million in Cash, a Proven Team and Deep Pipeline to Continue its Journey to Advance Science for Patients

Biohaven Ltd. (NYSE: BHVN) launched today as a new publicly traded company focused on delivering innovative life-changing treatments for neurological and neuropsychiatric diseases.

October 4, 2022
·
10 min read
Biotech Bay

Positive Results from Pivotal Trial of Better Therapeutics’ Investigational BT-001 Prescription Digital Therapy for Type 2 Diabetes Published in Diabetes Care

Positive Results from Pivotal Trial of Better Therapeutics’ Investigational BT-001 Prescription Digital Therapy for Type 2 Diabetes Published in Diabetes Care.

October 4, 2022
·
7 min read